ReviewObesity surgery2026
The Heresy of Hypoabsorptive Bariatric Surgery: A Critical Reappraisal of Long-Term Outcomes and Clinical Trade-Offs.
Review in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypoabsorptive bariatric procedures remain underutilized despite offering superior durable weight loss and metabolic comorbidity resolution. This review examines evidence from registry analyses, comparative studies, and long-term cohorts with follow-up extending to 30 years. When adjusted for baseline characteristics, hypoabsorptive procedures do not incur higher 30-day morbidity than RYGB. Five-year data confirm superiority in total weight loss (40.6% versus 33.8% for RYGB) and diabetes remission (92.8%). However, long-term follow-up reveals substantial nutritional costs affecting > 80% of patients in cohorts that often include patients treated with historical techniques, with cumulative reoperation rates reaching 37% at 10 years. Complication timing correlates with patient frailty-older age, lower BMI, and greater comorbidity burden predict earlier decompensation. Hypoabsorptive surgery offers unmatched efficacy at substantial long-term cost that manifests earlier in vulnerable populations, demanding rigorous patient selection and honest acknowledgment of trade-offs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.